Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Tokyo University researchers characterize new steroidal saponin

March 25, 1997

Daiichi discloses new antitumor agents

March 25, 1997

Preliminary phase I results for annamycin

March 21, 1997

Targretin enters phase II for diabetes

March 21, 1997

Matrix files NDA ammendment for AccuSite

March 21, 1997

U.S. researchers discover protein that inhibits apoptosis

March 21, 1997

Tumor-suppressing gene identified by scientists at Northwest Hospital

March 20, 1997

Antitumor/antiviral distamycin derivatives from P&U

March 19, 1997

Corixa and SmithKline Beecham collaborate on vaccine research

March 18, 1997

Pharmacokinetics of flavopiridol in patients

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...